The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results